Back To TOP

We Focus on Access so
You Can Focus on Health

Connecting your patients to ACTEMRA® (tocilizumab).
Welcome to Genentech Rheumatology Access Solutions
for ACTEMRA.

I am a
Learn More About
ACTEMRA
  • LEARN about treatment with ACTEMRA
  • NOW AVAILABLE: ACTEMRA SC for
    self-injection
  • LEARN HOW the ACT Fast Program can help ACTEMRA SC patients awaiting a coverage decision.
  • Download: new forms for enrollment in GATCF
  • Form Statement of Medical Necessity
  • Form Patient Authorization and Notice of Release of Information

The Access Solutions logo is a registered trademark of Genentech, Inc.